Abstract
5IL-2 therapy increases intratumoral FOXP3 + regulatory immune cells in patients with metastatic renal cell carcinoma
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have